RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 85 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,066,345 | +31.3% | 177,376 | -5.5% | 0.00% | 0.0% |
| Q2 2023 | $3,096,756 | +549.5% | 187,796 | +602.7% | 0.00% | – |
| Q1 2023 | $476,791 | -49.3% | 26,726 | -17.2% | 0.00% | – |
| Q4 2022 | $940,081 | -3.9% | 32,283 | -19.1% | 0.00% | – |
| Q3 2022 | $978,000 | +998.9% | 39,908 | +85.7% | 0.00% | – |
| Q2 2022 | $89,000 | -94.9% | 21,495 | -85.9% | 0.00% | – |
| Q1 2022 | $1,756,000 | +12.1% | 152,349 | -2.9% | 0.00% | – |
| Q4 2021 | $1,566,000 | -23.3% | 156,918 | +0.3% | 0.00% | – |
| Q3 2021 | $2,043,000 | -25.5% | 156,423 | +11.7% | 0.00% | -100.0% |
| Q2 2021 | $2,741,000 | -5.4% | 140,032 | +2.8% | 0.00% | 0.0% |
| Q1 2021 | $2,896,000 | -25.3% | 136,154 | +4.4% | 0.00% | 0.0% |
| Q4 2020 | $3,878,000 | +43.5% | 130,422 | +4.6% | 0.00% | 0.0% |
| Q3 2020 | $2,702,000 | -4.1% | 124,688 | -1.3% | 0.00% | 0.0% |
| Q2 2020 | $2,817,000 | +59.8% | 126,306 | +9.0% | 0.00% | 0.0% |
| Q1 2020 | $1,763,000 | -30.2% | 115,830 | +5.4% | 0.00% | 0.0% |
| Q4 2019 | $2,524,000 | +36.9% | 109,940 | +28.7% | 0.00% | 0.0% |
| Q3 2019 | $1,844,000 | -2.6% | 85,430 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $1,894,000 | -0.6% | 86,059 | +23.7% | 0.00% | 0.0% |
| Q1 2019 | $1,906,000 | +5.7% | 69,552 | +3.7% | 0.00% | 0.0% |
| Q4 2018 | $1,804,000 | +2.6% | 67,088 | +11.3% | 0.00% | – |
| Q3 2018 | $1,759,000 | +48.9% | 60,274 | +59.5% | 0.00% | – |
| Q2 2018 | $1,181,000 | +143.5% | 37,793 | +55.3% | 0.00% | – |
| Q1 2018 | $485,000 | -7.3% | 24,331 | +35.1% | 0.00% | – |
| Q4 2017 | $523,000 | – | 18,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 810,000 | $19,845,000 | 8.20% |
| NEA Management Company, LLC | 4,912,306 | $108,316,000 | 5.41% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $46,403,000 | 3.57% |
| RA Capital Management | 5,471,067 | $134,041,000 | 2.86% |
| Samsara BioCapital, LLC | 345,293 | $8,460,000 | 1.97% |
| Altium Capital Management LP | 170,000 | $4,165,000 | 1.53% |
| Parkman Healthcare Partners LLC | 187,989 | $4,606,000 | 1.31% |
| Rock Springs Capital Management LP | 1,760,865 | $43,141,000 | 1.11% |
| EAM Investors, LLC | 198,699 | $4,868,000 | 1.06% |
| Prosight Management, LP | 80,000 | $1,960,000 | 1.05% |